SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-21-036589
Filing Date
2021-07-13
Accepted
2021-07-12 18:08:20
Documents
45

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea144036-s1_inmedpharma.htm S-1 2452382
2 FORM OF SPECIFIC COMMON SHARE CERTIFICATE ea144036ex4-3_inmedpha.htm EX-4.3 1513
3 OPINION OF NORTON ROSE FULBRIGHT CANADA LLP ea144036ex5-1_inmedpha.htm EX-5.1 15508
4 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT, DATED MARCH 1, 2021, BETWEE ea144036ex10-3_inmedpha.htm EX-10.3 385700
5 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT, DATED MARCH 1, 2021, BETWEE ea144036ex10-4_inmedpha.htm EX-10.4 376939
6 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT, DATED MARCH 1, 2021, BETWEE ea144036ex10-5_inmedpha.htm EX-10.5 348414
7 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT, DATED MARCH 1, 2021, BETWEE ea144036ex10-6_inmedpha.htm EX-10.6 332978
8 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT, DATED MARCH 1, 2021, BETWEE ea144036ex10-7_inmedpha.htm EX-10.7 385233
9 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea144036ex23-1_inmedpha.htm EX-23.1 4026
10 GRAPHIC image_001.jpg GRAPHIC 15416
11 GRAPHIC image_002.jpg GRAPHIC 47878
12 GRAPHIC image_003.jpg GRAPHIC 75277
13 GRAPHIC image_004.jpg GRAPHIC 47878
14 GRAPHIC image_005.jpg GRAPHIC 113356
15 GRAPHIC image_006.jpg GRAPHIC 75277
16 GRAPHIC image_007.jpg GRAPHIC 104680
17 GRAPHIC image_008.jpg GRAPHIC 20376
18 GRAPHIC image_009.jpg GRAPHIC 111765
19 GRAPHIC image_010.jpg GRAPHIC 104171
20 GRAPHIC image_011.jpg GRAPHIC 81264
21 GRAPHIC image_012.jpg GRAPHIC 68463
22 GRAPHIC image_013.jpg GRAPHIC 67002
23 GRAPHIC image_014.jpg GRAPHIC 127491
24 GRAPHIC image_015.jpg GRAPHIC 53269
25 GRAPHIC image_016.jpg GRAPHIC 80929
26 GRAPHIC image_017.jpg GRAPHIC 164684
27 GRAPHIC image_018.jpg GRAPHIC 57185
28 GRAPHIC image_019.jpg GRAPHIC 55504
29 GRAPHIC image_020.jpg GRAPHIC 72851
30 GRAPHIC image_021.jpg GRAPHIC 109893
31 GRAPHIC image_022.jpg GRAPHIC 67126
32 GRAPHIC image_023.jpg GRAPHIC 64658
33 GRAPHIC image_024.jpg GRAPHIC 126873
34 GRAPHIC image_025.jpg GRAPHIC 129236
35 GRAPHIC image_026.jpg GRAPHIC 10117
36 GRAPHIC image_027.jpg GRAPHIC 4212
37 GRAPHIC ex4-3_001.jpg GRAPHIC 324019
38 GRAPHIC ex4-3_002.jpg GRAPHIC 119282
39 GRAPHIC ex5-1_001.jpg GRAPHIC 3540
40 GRAPHIC ex10-3_001.jpg GRAPHIC 10279
41 GRAPHIC ex10-4_001.jpg GRAPHIC 10279
42 GRAPHIC ex10-5_001.jpg GRAPHIC 10272
43 GRAPHIC ex10-6_001.jpg GRAPHIC 10279
44 GRAPHIC ex10-7_001.jpg GRAPHIC 10272
45 GRAPHIC ex23-1_001.jpg GRAPHIC 4518
  Complete submission text file 0001213900-21-036589.txt   7833432
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: S-1 | Act: 33 | File No.: 333-257858 | Film No.: 211086311
SIC: 2834 Pharmaceutical Preparations